rosiglitazone has been researched along with fludrocortisone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ince, P; Munir, A; Newell-Price, J; Ross, R; Song, F; Walters, SJ | 1 |
1 review(s) available for rosiglitazone and fludrocortisone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for rosiglitazone and fludrocortisone
| Article | Year |
|---|---|
Ineffectiveness of rosiglitazone therapy in Nelson's syndrome.
Topics: ACTH-Secreting Pituitary Adenoma; Adrenocorticotropic Hormone; Adult; Aged; Anti-Inflammatory Agents; Female; Fludrocortisone; Humans; Hydrocortisone; Hypoglycemic Agents; Magnetic Resonance Imaging; Male; Nelson Syndrome; Pancreatitis; Pituitary ACTH Hypersecretion; Pituitary Gland; Pituitary Neoplasms; PPAR gamma; Rosiglitazone; Thiazolidinediones; Tomography, X-Ray Computed | 2007 |